Company Filing History:
6 out of 21 
2 out of 73 
1 out of 16 
Years Active: 2000-2019
Title: **Innovative Contributions of Robert G Van Buskirk**
Introduction
Robert G Van Buskirk, an inventive mind based in Apalachin, NY, has made remarkable strides in the field of biomedical engineering. With a portfolio of 10 patents, he has contributed significantly to advancements in cellular therapies and cryogenic medical technologies.
Latest Patents
Among his latest innovations is the patent titled "Method of Molecular Stress Control". This groundbreaking invention identifies a novel class of agents that act as cell-guard agents and target-specific supplements aimed at enhancing cell quality and yield. Notable agents identified include Vitamin D3, NAC, resveratrol, salubrinal, AKT, and tunicamycin. The patent benefits from the application of both hypothermic stress regimes and normothermic conditions to optimize cell processing for research and clinical use, marking an important milestone in therapeutic discovery. Additionally, his "Cryogenic Medical System" patent introduces devices capable of generating cryogen to a supercritical state, particularly supercritical nitrogen, serving as valuable tools in treating damaged or cancerous tissues.
Career Highlights
Van Buskirk has held positions with key companies in the medical field, including Cpsi Holdings LLC and Endocare, Inc. His work in these organizations reflects his dedication to translating innovative ideas into practical applications, particularly in medical treatments and procedures.
Collaborations
Throughout his career, Robert has collaborated with notable figures such as John M Baust and John G Baust. These partnerships have allowed for the exchange of ideas and expertise, further enriching his contributions to the field.
Conclusion
Robert G Van Buskirk exemplifies the spirit of innovation within the medical technology sector. His patents not only demonstrate his technical skill and creativity but also hold the potential to significantly impact therapeutic practices. As he continues to develop new solutions, his influence on the industry is sure to grow, paving the way for future advancements in healthcare.